Marlboro-Chesterfield Pathology, a North Carolina-based molecular and cytology lab, agreed to settle a class action lawsuit stemming from a 2025 ransomware attack. The attack compromised patient data, disrupted lab operations, and triggered the legal liability that healthcare organizations dread most: a breach of protected health information under HIPAA.
Pathology labs are high-value targets. They handle biopsy results, cancer diagnoses, genetic testing data, and other deeply sensitive PHI. They also run a lot of specialized equipment locked to older Windows versions — lab instruments, imaging systems, and diagnostic software that can’t be upgraded without breaking FDA-validated workflows.
That combination — critical data and legacy infrastructure — makes them perfect victims.
Why the Attack Worked
Ransomware follows a predictable pattern. The payload arrives via email attachment, compromised credentials, or an exploited remote access service. It writes an executable file to disk. It runs. It encrypts everything it can reach. Then it demands payment.
Every one of those steps involves file operations: writing the payload, writing the encrypted versions of your files, deleting or overwriting the originals. If you can block unauthorized programs from writing executable files to disk, the attack stops at step one. The payload never lands. Encryption never starts.
Most endpoint security tools try to detect ransomware after it’s already written to disk — signature matching, behavioral analysis, machine learning models trained on known variants. That’s downstream. By the time detection happens, you’re in damage control mode.
FileSure Defend operates upstream. It enforces file access policies at the kernel level via a Windows filter driver. Unauthorized programs cannot write executable files, period. No signature database. No behavior analysis. No waiting to see if the file does something bad. The operation is blocked before the file system processes it.
The FileSure Rule That Applies
Here’s the specific policy that would have stopped this attack:
File name filter: *.exe, *.dll, *.bat, *.cmd, *.ps1, *.vbs, *.scr
Operations blocked: Create, Write
Authorized programs: Only IT-approved application installers and update mechanisms
Scope: All local drives and network shares
Email clients, browsers, and remote desktop sessions are not on the authorized list. If Outlook tries to write an executable to disk, it gets blocked. If a PowerShell script launched from a phishing email tries to download and write a payload, it gets blocked. The ransomware never gets a foothold.
And because FileSure runs on legacy Windows versions — the ones modern endpoint tools won’t touch — those lab instrument systems running Windows 7 or Server 2008 R2 are protected too.
The Compliance Problem Nobody Talks About
The lawsuit isn’t just about the ransomware. It’s about the breach notification failure, the lack of audit trails, and the inability to prove what happened to patient data.
HIPAA’s Security Rule requires covered entities to implement audit controls: hardware, software, and procedural mechanisms that record and examine activity in systems containing ePHI. That means logging who accessed which patient files, when, with what program, and from which machine.
Most organizations rely on Windows Event Logs for this. The problem: those logs weren’t designed for HIPAA compliance. They’re verbose, they roll over quickly under audit-everything policies, and they don’t natively track file-level access in a way that’s useful for breach investigation.
FileSure logs every file operation on PHI: read, write, create, delete, rename. User name, program name, machine name, timestamp, file path. The logs are encrypted, tamper-resistant, and stored separately from the files they record. When OCR or a plaintiff’s attorney asks for proof of who accessed what, the data exists.
For Marlboro-Chesterfield Pathology, that audit trail would have shown exactly which files were accessed during the attack window, which accounts were involved, and whether any unauthorized exfiltration occurred before encryption. That’s the evidence you need to limit legal exposure and satisfy breach notification requirements.
Protecting Pathology Labs
If you run a pathology lab, imaging center, or any healthcare operation with legacy Windows systems, you have two problems: you can’t install modern security tools on those systems, and you can’t afford to leave them unprotected.
FileSure Defend solves both. It installs on Windows XP through Windows 11, Server 2003 through Server 2025. It blocks ransomware at the file system layer. It generates HIPAA-compliant audit logs automatically. And it does all of this without requiring you to rip out and replace the specialized medical systems your operations depend on.
The scumbags who hit Marlboro-Chesterfield Pathology didn’t need a zero-day exploit or advanced persistent threat tactics. They just needed to write a file to disk. If you can prevent that, you prevent the attack.
Start a free 21-day trial of FileSure Defend at bystorm.com. No credit card required. Protect your patient data and your legacy systems at the same time.
Source: Marlboro-Chesterfield Pathology Agrees to Settle Lawsuit Over 2025 Ransomware Attack
Category: Ransomware
Tags: ransomware, hipaa compliance, pathology lab, healthcare data breach, kernel filter driver, phi protection, legacy windows systems, audit controls
